Form 4: Paylocity Holding Corp: Director Steven I. Sarowitz Executes Stock Sales Under 10b5-1 Plan
SEC Form 4
Director Steven I. Sarowitz sold shares of Paylocity Holding Corp (PCTY) on November 4, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On November 4, 2024, Steven I. Sarowitz, a Director and 10% Owner of Paylocity Holding Corp (PCTY), executed multiple sales of common stock.
- These transactions were conducted under a pre-approved 10b5-1 trading plan adopted on September 15, 2023.
- The sales occurred at varying weighted average prices: $189.05 for 400 shares, $190.51 for 1,900 shares, $191.54 for 11,265 shares, and $192.31 for 2,700 shares.
- Following these transactions, Sarowitz directly owns 9,472,471 shares of Paylocity common stock.
- Additionally, Sarowitz indirectly owns 20,000 shares through the Jessica P. Sarowitz Declaration of Trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Sales by insiders are a common occurrence, especially when executed under pre-arranged trading plans like 10b5-1 plans. These plans allow insiders to sell shares over a period of time without being accused of trading on non-public information. The market typically views these sales in the context of the overall financial health and future prospects of the company.
Comparison to Industry Standards
- Comparing Sarowitz's transactions to those of insiders at similar companies like Workday (WDAY) or Automatic Data Processing (ADP) would require analyzing their Form 4 filings for similar sales patterns under 10b5-1 plans.
- Generally, insider sales are benchmarked against the company's stock performance, industry trends, and overall market conditions to determine if they are indicative of any specific concerns or simply routine diversification strategies.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders if they interpret the sales negatively, potentially leading to slight selling pressure.
- However, given the pre-arranged nature of the 10b5-1 plan, the impact is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 2023-09-15 | Date the reporting person adopted the 10b5-1 Plan |
| 2024-11-04 | Date of the stock sales |
| 2024-11-06 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.